Business Context and Reporting Period
Company: CTS Corporation (CTS)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended April 4, 2010
Business Overview: CTS is a global manufacturer of components and sensors primarily for automotive, communications, and defense/aerospace markets. It also provides electronic manufacturing solutions (EMS) under contract arrangements. The company operates through two reportable segments: Components and Sensors, and EMS.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $129.4 million | $118.1 million |
| Gross Margin | $30.5 million (23.6%) | $19.8 million (16.8%) |
| Operating Earnings | $6.3 million | ($35.5 million) loss |
| Net Earnings | $4.4 million | ($35.6 million) loss |
| Diluted EPS | $0.13 | ($1.06) |
| Cash and Equivalents | $58.8 million | $44.6 million |
| Long-Term Debt | $56.0 million | $50.4 million |
| Operating Cash Flow | $5.3 million | ($4.0 million) used |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.5% year-over-year, driven primarily by a 73.6% surge in the Components and Sensors segment. This growth was offset by a 26.2% decline in the EMS segment due to planned end-of-life sales reductions (specifically to Hewlett-Packard) and program delays in defense and medical markets.
- Profitability Turnaround: The company returned to profitability with $4.4 million in net earnings, compared to a $35.6 million loss in Q1 2009. The prior year loss was significantly impacted by a $33.2 million non-cash goodwill impairment charge and $2.2 million in restructuring charges, neither of which occurred in Q1 2010.
- Margin Expansion: Gross margin improved to 23.6% from 16.8%, attributed to a favorable shift in sales mix toward the higher-margin Components and Sensors segment and an improved cost structure.
- Expense Increases: Selling, general, and administrative (SG&A) expenses rose to $19.5 million from $16.6 million, reflecting increased spending to support higher sales and the reinstatement of compensation items suspended during the 2009 recession. R&D expenses also increased to $4.6 million from $3.4 million.
Guidance, Outlook, and Risks
Outlook and Guidance
Management has raised its full-year 2010 guidance based on first-quarter results:
- Sales: Anticipated to increase 12% - 20% over 2009 (previously 10% - 15%).
- Diluted EPS: Estimated in the range of $0.52 to $0.60 (previously $0.45 to $0.53).
Risks and Contingencies
- Toyota Recall Litigation: CTS manufactures accelerator pedals for Toyota. Following a January 2010 recall of approximately 2.3 million vehicles, CTS is a co-defendant in various litigation. In February 2010, CTS entered an indemnification agreement with Toyota, which agreed to defend and hold CTS harmless from third-party civil claims arising from unintended acceleration incidents, with limited exceptions restricted to amounts collectible from CTS's insurers.
- Environmental Liabilities: CTS faces potential liability for hazardous waste remediation at various sites. Management believes adequate provisions have been made or that costs will not materially affect financial position.
- Market Risks: The company faces risks related to rapid technological change, reliance on key customers, pricing pressures, and international operations including exchange rate fluctuations.
Investor Verification Checklist
- Toyota Indemnification Scope: Verify the specific limitations of the indemnification agreement with Toyota regarding the accelerator pedal recall and potential liability exposure.
- EMS Segment Recovery: Monitor the trajectory of the EMS segment, which saw a 26.2% sales decline, to determine if the drop is temporary or indicative of a structural shift in the customer base.
- Debt Covenant Compliance: Confirm continued compliance with the revolving credit agreement covenants (maximum total leverage ratio and minimum fixed charge coverage ratio), especially as debt levels increased to fund working capital.
- Guidance Realization: Track subsequent quarterly results to assess the feasibility of the raised full-year sales and EPS guidance in the context of global economic conditions.